Press Releases in 2018

Check out the latest press releases from Novus. For direct media requests, contact us at
View Press Releases From: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

Release Date: 
Tuesday, July 10, 2018 - 00:00

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

MINNEAPOLIS, July 10, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using recent advances in gene editing technology.

Bio-Techne Leads the Way in Scientific Support for Autophagy Research

Release Date: 
Thursday, April 26, 2018 - 00:00

MINNEAPOLIS, April 26, 2018 /PRNewswire/ -- Bio-Techne, a family of brands providing a unique portfolio of products and services for basic and clinical research, has a leading role supporting autophagy research.

Autophagy (or "self-eating") is an important basic cellular process by which cell components are degraded by lysosomes or vacuoles and recycled. Autophagy plays a crucial role in human health and disease. Disrupted autophagy has been implicated in Parkinson's disease, type 2 diabetes, cancer, and is now a major target for drug discovery and development.

Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development

Release Date: 
Wednesday, March 21, 2018 - 00:00

New and updated assays increase application areas and improve performance

Bio-Techne Acquires Atlanta Biologicals Inc,

Release Date: 
Tuesday, January 2, 2018 - 12:00

MINNEAPOLIS, Jan. 2, 2018 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand.